Skip to main content
SpringerLink
Log in

Malignant syndrome triggered by influenza A virus infection in a patient with Parkinson’s disease with improvement after intravenous peramivir treatment

  • Letter to the Editor
  • Published:
Neurological Sciences Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

References

  1. Hashimoto T, Tokuda T, Hanyu N, Tabata K, Yanagisawa N (2003) Withdrawal of levodopa and other risk factors for malignant syndrome in Parkinson's disease. Parkinsonism Relat Disord 9(Suppl 1):S25–S30

    Article  PubMed  Google Scholar 

  2. Ogawa E, Sakakibara R, Kishi M, Tateno F (2012) Constipation triggered the malignant syndrome in Parkinson's disease. Neurol Sci 33:347–350

    Article  PubMed  Google Scholar 

  3. Levenson JL (1985) Neuroleptic malignant syndrome. Am J Psychiatry 142:1137–1145

    Article  CAS  PubMed  Google Scholar 

  4. Takubo H, Harada T, Hashimoto T et al (2003) A collaborative study on the malignant syndrome in Parkinson's disease and related disorders. Parkinsonism Relat Disord 9(Suppl 1):S31–S41

    Article  PubMed  Google Scholar 

  5. Lattanzi L, Mungai F, Romano A, Bonuccelli U, Cassano GB, Fagiolini A (2006) Subcutaneous apomorphine for neuroleptic malignant syndrome. Am J Psychiatry 163:1450–1451

    Article  PubMed  Google Scholar 

  6. Cox B, Lee TF (1977) Do central dopamine receptors have a physiological-role in thermoregulation. Br J Pharmacol 61:83–86

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  7. Shetty AK, Peek LA (2012) Peramivir for the treatment of influenza. Expert Rev Anti-Infect Ther 10:123–143

    Article  CAS  PubMed  Google Scholar 

  8. Sugaya N, Kohno S, Ishibashi T, Wajima T, Takahashi T (2012) Efficacy, safety, and pharmacokinetics of intravenous peramivir in children with 2009 pandemic H1N1 influenza A virus infection. Antimicrob Agents Chemother 56:369–377

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We appreciate the cooperation of the patient. We also thank Angela Morben, DVM, ELS, from Edanz Group (www.edanzediting.com/ac) for editing a draft of this manuscript.

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Imai Hospital, Tochigi, Japan

    Kosuke Matsuzono, Masamichi Baba, Goro Imai & Hiroaki Imai

  2. Division of Neurology, Department of Internal Medicine, Jichi Medical University School of Medicine, Yakushiji 3311-1, Shimotsuke, Tochigi, 329-0498, Japan

    Kosuke Matsuzono & Shigeru Fujimoto

Authors
  1. Kosuke Matsuzono
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Masamichi Baba
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Goro Imai
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Hiroaki Imai
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Shigeru Fujimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

K.M., M.B., G. I, and H.I. were the attending doctors in the present case. K.M. drafted the manuscript. S.F. conceived the study, participated in its coordination, and helped to draft the manuscript. All authors read and approved the final manuscript.

Corresponding author

Correspondence to Kosuke Matsuzono.

Ethics declarations

Conflict of interest

The authors declare that they have no competing interests.

Ethical standards

Informed consent was obtained from the patient described in this article.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Matsuzono, K., Baba, M., Imai, G. et al. Malignant syndrome triggered by influenza A virus infection in a patient with Parkinson’s disease with improvement after intravenous peramivir treatment. Neurol Sci 40, 1291–1294 (2019). https://doi.org/10.1007/s10072-018-3696-4

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10072-018-3696-4

Search

Navigation